389 related articles for article (PubMed ID: 15908510)
1. Resting and evoked spinal substance P release during chronic intrathecal morphine infusion: parallels with tolerance and dependence.
Gu G; Kondo I; Hua XY; Yaksh TL
J Pharmacol Exp Ther; 2005 Sep; 314(3):1362-9. PubMed ID: 15908510
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release.
Kondo I; Marvizon JC; Song B; Salgado F; Codeluppi S; Hua XY; Yaksh TL
J Neurosci; 2005 Apr; 25(14):3651-60. PubMed ID: 15814796
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of antinociception of spinal galanin: how does galanin inhibit spinal sensitization?
Hua XY; Salgado KF; Gu G; Fitzsimmons B; Kondo I; Bartfai T; Yaksh TL
Neuropeptides; 2005 Jun; 39(3):211-6. PubMed ID: 15944014
[TBL] [Abstract][Full Text] [Related]
4. GABA(A) receptor facilitation of neurokinin release from primary afferent terminals in the rat spinal cord.
Lao L; Marvizón JC
Neuroscience; 2005; 130(4):1013-27. PubMed ID: 15652997
[TBL] [Abstract][Full Text] [Related]
5. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.
Dunbar SA; Pulai IJ
J Pharmacol Exp Ther; 1998 Feb; 284(2):678-86. PubMed ID: 9454814
[TBL] [Abstract][Full Text] [Related]
6. Co-administration of ultra-low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal cords.
Lin SL; Tsai RY; Shen CH; Lin FH; Wang JJ; Hsin ST; Wong CS
Pharmacol Biochem Behav; 2010 Aug; 96(2):236-45. PubMed ID: 20478329
[TBL] [Abstract][Full Text] [Related]
7. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
8. Spinal N-methyl-D-aspartate receptors and nociception-evoked release of primary afferent substance P.
Nazarian A; Gu G; Gracias NG; Wilkinson K; Hua XY; Vasko MR; Yaksh TL
Neuroscience; 2008 Mar; 152(1):119-27. PubMed ID: 18222611
[TBL] [Abstract][Full Text] [Related]
9. Spinal amino acid release and repeated withdrawal in spinal morphine tolerant rats.
Ibuki T; Marsala M; Masuyama T; Yaksh TL
Br J Pharmacol; 2003 Feb; 138(4):689-97. PubMed ID: 12598423
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal substance P (1-7) prevents morphine-evoked spontaneous pain behavior via spinal NMDA-NO cascade.
Sakurada T; Komatsu T; Kuwahata H; Watanabe C; Orito T; Sakurada C; Tsuzuki M; Sakurada S
Biochem Pharmacol; 2007 Sep; 74(5):758-67. PubMed ID: 17658485
[TBL] [Abstract][Full Text] [Related]
11. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
Kreeger JS; Larson AA
J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
[TBL] [Abstract][Full Text] [Related]
12. The role of spinal neuropeptides and prostaglandins in opioid physical dependence.
Trang T; Sutak M; Quirion R; Jhamandas K
Br J Pharmacol; 2002 May; 136(1):37-48. PubMed ID: 11976266
[TBL] [Abstract][Full Text] [Related]
13. Cross talk between nitric oxide and ERK1/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats.
Cao JL; Liu HL; Wang JK; Zeng YM
Neuropharmacology; 2006 Aug; 51(2):315-26. PubMed ID: 16712881
[TBL] [Abstract][Full Text] [Related]
14. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
15. Effects of recurrent withdrawal on spinal GABA release during chronic morphine infusion in the rat.
Dunbar SA; Karamian I; Yeatman A; Zhang J
Eur J Pharmacol; 2006 Mar; 535(1-3):152-6. PubMed ID: 16540107
[TBL] [Abstract][Full Text] [Related]
16. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats.
Tai YH; Wang YH; Wang JJ; Tao PL; Tung CS; Wong CS
Pain; 2006 Sep; 124(1-2):77-86. PubMed ID: 16697108
[TBL] [Abstract][Full Text] [Related]
17. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine.
Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI
Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361
[TBL] [Abstract][Full Text] [Related]
18. [The role of the spinal cord inducible nitric oxide synthase in morphine dependence and naloxone-precipitated withdrawal rats].
Liu HL; Qian YN; Li XC
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Jan; 28(1):49-52. PubMed ID: 22493895
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia.
Johnston IN; Westbrook RF
Behav Brain Res; 2005 Jan; 156(1):75-83. PubMed ID: 15474652
[TBL] [Abstract][Full Text] [Related]
20. Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine.
Jhamandas KH; Marsala M; Ibuki T; Yaksh TL
J Neurosci; 1996 Apr; 16(8):2758-66. PubMed ID: 8786451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
